{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:42:40Z","timestamp":1790404960640,"version":"4.1.0"},"reference-count":43,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Ethics"],"accepted":{"date-parts":[[2017,10,6]]},"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain and potentially high risk, with minimal chance of clinical benefit. Some question whether such trials should be offered, given the risk\/benefit imbalance, and whether those who choose to participate are acting rationally. We address these questions through a longitudinal decision-making study nested in a Thai acute HIV research cohort.<\/jats:p>\n                  <jats:p>In-depth interviews revealed central themes about decisions to join. Participants felt they possessed an important identity as members of the acute cohort, viewing their bodies as uniquely suited to both testing and potentially benefiting from HIV cure approaches. While acknowledging risks of ATI, most perceived they were given an opportunity to interrupt treatment, to test their own bodies and increase normalcy in a safe, highly monitored circumstance. They were motivated by potential benefits to themselves, the investigators and larger acute cohort, and others with HIV. They believed their own trial experiences and being able to give back to the community were sufficient to offset participation risks.<\/jats:p>\n                  <jats:p>These decisions were driven by the specific circumstances experienced by our participants. Judging risk\/benefit ratios without appreciating these lived experiences can lead to false determinations of irrational decision- making. While this does not minimise vital oversight considerations about risk reduction and protection from harm, it argues for inclusion of a more participant-centered approach.<\/jats:p>","DOI":"10.1136\/medethics-2017-104433","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T20:35:15Z","timestamp":1510346115000},"page":"270-276","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk\/benefit assessment"],"prefix":"10.1136","volume":"44","author":[{"given":"Gail E","family":"Henderson","sequence":"first","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly L","family":"Peay","sequence":"additional","affiliation":[{"name":"Center for Newborn Screening, Ethics, and Disability Studies, RTI International, Research Triangle Park, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Kroon","sequence":"additional","affiliation":[{"name":"SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary Jean","family":"Cadigan","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Meagher","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thidarat","family":"Jupimai","sequence":"additional","affiliation":[{"name":"Clinical Research Associates Department, HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Gilbertson","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuchanart Q","family":"Ormsby","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitiya","family":"Chomchey","sequence":"additional","affiliation":[{"name":"SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[{"name":"SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[{"name":"SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand"},{"name":"Walter Reed Army Institute of Research, Silver Spring, Maryland, USA"},{"name":"Retrovirology Department, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Rennie","sequence":"additional","affiliation":[{"name":"Department of Social Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"2025092415184160000_44.4.270.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61809-7"},{"key":"2025092415184160000_44.4.270.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110187"},{"key":"2025092415184160000_44.4.270.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"2025092415184160000_44.4.270.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0440-y"},{"key":"2025092415184160000_44.4.270.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6517"},{"key":"2025092415184160000_44.4.270.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4108"},{"key":"2025092415184160000_44.4.270.7","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016-103427"},{"key":"2025092415184160000_44.4.270.8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/QAD.0000000000000210","article-title":"Rennie S, and the Social Ethical Working Group on HIV Cure. Social and ethical implications of HIV cure research","volume":"28","author":"Tucker","year":"2014","journal-title":"AIDS"},{"key":"2025092415184160000_44.4.270.9","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32835ea1c5"},{"key":"2025092415184160000_44.4.270.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62040-1"},{"key":"2025092415184160000_44.4.270.11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7326\/0003-4819-159-7-201310010-00694","article-title":"HIV cure research: expanding the ethical considerations","volume":"159","author":"Sugarman","year":"2013","journal-title":"Ann Intern Med"},{"key":"2025092415184160000_44.4.270.12","unstructured":"Sugarman J . Ethics of Curing HIV: Roundtable Discussion Talk. 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention. Kuala Lumpur, 2013."},{"key":"2025092415184160000_44.4.270.13","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2352-3018(15)00248-9","article-title":"Ethics of ART interruption after stem-cell transplantation","volume":"3","author":"Sugarman","year":"2016","journal-title":"Lancet HIV"},{"key":"2025092415184160000_44.4.270.14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2055-6640(20)30287-9","article-title":"Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations","volume":"3","author":"Garner","year":"2017","journal-title":"J Virus Erad"},{"key":"2025092415184160000_44.4.270.15","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2015-103115"},{"key":"2025092415184160000_44.4.270.16","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016-103428"},{"key":"2025092415184160000_44.4.270.17","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2015-103119"},{"key":"2025092415184160000_44.4.270.18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1353\/ken.2008.0004","article-title":"The harm-benefit tradeoff in \"bad deal\" trials","volume":"17","author":"Nycum","year":"2007","journal-title":"Kennedy Inst Ethics J"},{"key":"2025092415184160000_44.4.270.19","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2015-103123"},{"key":"2025092415184160000_44.4.270.20","doi-asserted-by":"crossref","unstructured":"Gilbertson A . Unanticipated participant benefits in HIV cure clinical research: A qualitative analysis. Durban, South Africa: International AIDS Society Towards an HIV Cure Symposium, 2016.","DOI":"10.1016\/S2055-6640(20)31005-0"},{"key":"2025092415184160000_44.4.270.21","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2015-103120"},{"key":"2025092415184160000_44.4.270.22","first-page":"10","article-title":"Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US","volume":"3","author":"Dub\u00e9","year":"2017","journal-title":"J Virus Erad"},{"key":"2025092415184160000_44.4.270.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170112","article-title":"\u2019Well, It\u2019s the Risk of the Unknown\u2026 Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States","volume":"12","author":"Dub\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"2025092415184160000_44.4.270.24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2055-6640(20)31143-2","article-title":"What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent","volume":"1","author":"Peay","year":"2015","journal-title":"Journal of Virus Eradication"},{"key":"2025092415184160000_44.4.270.25","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2014.0219"},{"key":"2025092415184160000_44.4.270.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033948","article-title":"Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection","volume":"7","author":"Ananworanich","year":"2012","journal-title":"PLoS One"},{"key":"2025092415184160000_44.4.270.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw365"},{"key":"2025092415184160000_44.4.270.28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9495"},{"key":"2025092415184160000_44.4.270.29","unstructured":"Journal of the International AIDS Society. In: Kroon E , Ananworanich J , Eubanks K , Intasan J , Pinyakorn S , et al . eds. Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection. Geneva,\u00a0Switzerland: INT AIDS Society avenue de France 23, 2016."},{"key":"2025092415184160000_44.4.270.30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08989621.2016.1198978","article-title":"The Role of Intuition in Risk\/Benefit Decision-Making in Human Subjects Research","volume":"24","author":"Resnik","year":"2017","journal-title":"Account Res"},{"key":"2025092415184160000_44.4.270.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-9566.2003.00369.x"},{"key":"2025092415184160000_44.4.270.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2000.tb00685.x"},{"key":"2025092415184160000_44.4.270.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8519.2010.01825.x"},{"key":"2025092415184160000_44.4.270.34","doi-asserted-by":"publisher","DOI":"10.1177\/1049732310375818"},{"key":"2025092415184160000_44.4.270.35","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200101000-00002"},{"key":"2025092415184160000_44.4.270.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040324"},{"key":"2025092415184160000_44.4.270.37","doi-asserted-by":"publisher","DOI":"10.1017\/S096318011400053X"},{"key":"2025092415184160000_44.4.270.38","unstructured":"King NMP , Henderson GE , Stein J . Relationships in research: a new paradigm. in:\u00a0Beyond regulations: ethics in human subjects research. Chapel Hill, NC:\u00a0University of North Carolina Press. 1999:1\u201318."},{"key":"2025092415184160000_44.4.270.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70400-2"},{"key":"2025092415184160000_44.4.270.40","doi-asserted-by":"crossref","unstructured":"King NM , Churchill LR . Assessing and comparing potential benefits and risks of harm. The Oxford Textbook of Clinical Research Ethics. Oxford: Oxford University Press, 2008:514\u201326.","DOI":"10.1093\/oso\/9780195168655.003.0049"},{"key":"2025092415184160000_44.4.270.41","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2015-103118"},{"key":"2025092415184160000_44.4.270.42","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(13)61575-5","article-title":"The right to participate in high-risk research","volume":"383","author":"Shaw","year":"2014","journal-title":"The Lancet"},{"key":"2025092415184160000_44.4.270.43","unstructured":"Thailand Family Law Center. Demystifying Kreng Jai 2012. http:\/\/www.thailand-family-law-center.com\/demystifying-kreng-jai\/ (26 May 2016)."}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medethics-2017-104433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T22:18:49Z","timestamp":1758752329000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/medethics-2017-104433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1136\/medethics-2017-104433"],"URL":"https:\/\/doi.org\/10.1136\/medethics-2017-104433","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}